219 related articles for article (PubMed ID: 35338580)
21. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data.
Bertholim-Nasciben L; Scliar MO; Debortoli G; Thiruvahindrapuram B; Scherer SW; Duarte YAO; Zatz M; Suarez-Kurtz G; Parra EJ; Naslavsky MS
Front Pharmacol; 2023; 14():1178715. PubMed ID: 37234706
[No Abstract] [Full Text] [Related]
22. The pharmacogenomic landscape of an Indigenous Australian population.
Samarasinghe SR; Hoy W; Jadhao S; McMorran BJ; Guchelaar HJ; Nagaraj SH
Front Pharmacol; 2023; 14():1180640. PubMed ID: 37284308
[No Abstract] [Full Text] [Related]
23. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
[TBL] [Abstract][Full Text] [Related]
24. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
[TBL] [Abstract][Full Text] [Related]
25. A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.
Huang Q; Liao Y; Yu T; Lei W; Liang H; Wen J; Liu Q; Chen Y; Huang K; Jing L; Huang X; Liu Y; Yu X; Su K; Liu T; Yang L; Huang M
J Clin Lab Anal; 2023 Mar; 37(5):e24855. PubMed ID: 36916827
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
Alshabeeb MA; Alyabsi M; Paras B
Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
[TBL] [Abstract][Full Text] [Related]
27. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
[TBL] [Abstract][Full Text] [Related]
28. Whole-genome sequencing of 1029 Indian individuals reveals unique and rare structural variants.
Divakar MK; Jain A; Bhoyar RC; Senthivel V; Jolly B; Imran M; Sharma D; Bajaj A; Gupta V; Scaria V; Sivasubbu S
J Hum Genet; 2023 Jun; 68(6):409-417. PubMed ID: 36813834
[TBL] [Abstract][Full Text] [Related]
29. A New Cloud-Native Tool for Pharmacogenetic Analysis.
Yuan DY; Park JH; Li Z; Thomas R; Hwang DM; Fu L
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540411
[TBL] [Abstract][Full Text] [Related]
30. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.
Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D
PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958
[TBL] [Abstract][Full Text] [Related]
31. Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase.
Georgitsi M; Viennas E; Gkantouna V; Christodoulopoulou E; Zagoriti Z; Tafrali C; Ntellos F; Giannakopoulou O; Boulakou A; Vlahopoulou P; Kyriacou E; Tsaknakis J; Tsakalidis A; Poulas K; Tzimas G; Patrinos GP
Pharmacogenomics; 2011 Jan; 12(1):49-58. PubMed ID: 21174622
[TBL] [Abstract][Full Text] [Related]
32. Clinical implementation of preemptive pharmacogenomics in psychiatry.
Skokou M; Karamperis K; Koufaki MI; Tsermpini EE; Pandi MT; Siamoglou S; Ferentinos P; Bartsakoulia M; Katsila T; Mitropoulou C; Patrinos GP;
EBioMedicine; 2024 Mar; 101():105009. PubMed ID: 38364700
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomics: Current Actionable Variants.
González-Covarrubias V; Lozano K; Texis T; Guzmán-Cruz CK; Rodríguez-Dorantes M; Rubio-Carrasco K; Méndez-Lorenzo LH; Soberón X
Rev Invest Clin; 2020 May; 73(3):. PubMed ID: 32488227
[TBL] [Abstract][Full Text] [Related]
34. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive characterization of pharmacogenes in a Taiwanese Han population.
Lu HF; Liu TY; Chou YP; Chang SS; Hsieh YW; Chang JG; Tsai FJ
Front Genet; 2022; 13():948616. PubMed ID: 36092904
[TBL] [Abstract][Full Text] [Related]
36. Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations.
Al-Mahayri ZN; Patrinos GP; Wattanapokayakit S; Iemwimangsa N; Fukunaga K; Mushiroda T; Chantratita W; Ali BR
Sci Rep; 2020 Dec; 10(1):21310. PubMed ID: 33277594
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.
Jmel H; Romdhane L; Ben Halima Y; Hechmi M; Naouali C; Dallali H; Hamdi Y; Shan J; Abid A; Jamoussi H; Trabelsi S; Chouchane L; Luiselli D; Abdelhak S; Kefi R
PLoS One; 2018; 13(4):e0194842. PubMed ID: 29652911
[TBL] [Abstract][Full Text] [Related]
38. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care.
Bank PCD; Swen JJ; Schaap RD; Klootwijk DB; Baak-Pablo R; Guchelaar HJ
Eur J Hum Genet; 2019 Oct; 27(10):1532-1541. PubMed ID: 31227807
[TBL] [Abstract][Full Text] [Related]
39. Applying an equity lens to pharmacogenetic research and translation to under-represented populations.
Luczak T; Stenehjem D; Brown J
Clin Transl Sci; 2021 Nov; 14(6):2117-2123. PubMed ID: 34268895
[TBL] [Abstract][Full Text] [Related]
40. Personalized medicine: Genetic risk prediction of drug response.
Zhang G; Nebert DW
Pharmacol Ther; 2017 Jul; 175():75-90. PubMed ID: 28213088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
